Skip to main content

Table 1 Characterization of AGE-LDL

From: Immunization with advanced glycation end products modified low density lipoprotein inhibits atherosclerosis progression in diabetic apoE and LDLR null mice

  nLDL ox-LDL AGE-LDL
TBA (nmoles HMF/mg protein) 1.92 ± 1.30 4.41 ± 1.22* 7.35 ± 0.83**#
TNBSA (AU) 0.45 ± 0.08 0.40 ± 0.07* 0.32 ± 0.04*
TBARS (nmoles MDA/mg protein) 0.30 ± 0.21 4.17 ± 0.06** 1.82 ± 0.31*#
Rf (cm) 0.51 ± 0.05 0.63 ± 0.08* 0.74 ± 0.05*
  1. *indicates p < 0.05 vs. nLDL, **indicates p < 0.01 vs. nLDL and #indicates p < 0.05 vs. ox-LDL; nLDL: native low density lipoprotein; TBA: thiobarbituric assay; HMF: 5-hydroxymethylfurfural; TNBSA: trinitrobenzene sulphonic acid assay; TBARS: thiobarbituric acid reactive substances; MDA: malondialdehyde; Rf: relative electrophoretic mobility by agarose gel electrophoresis.